1. Home
  2. UEIC vs XLO Comparison

UEIC vs XLO Comparison

Compare UEIC & XLO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Universal Electronics Inc.

UEIC

Universal Electronics Inc.

HOLD

Current Price

$5.17

Market Cap

58.2M

ML Signal

HOLD

XLO

Xilio Therapeutics Inc.

N/A

Current Price

$9.04

Market Cap

56.9M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
UEIC
XLO
Founded
1986
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Consumer Electronics/Appliances
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Staples
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
58.2M
56.9M
IPO Year
1995
2021

Fundamental Metrics

Financial Performance
Metric
UEIC
XLO
Price
$5.17
$9.04
Analyst Decision
Hold
Buy
Analyst Count
1
1
Target Price
$3.50
★ $28.00
AVG Volume (30 Days)
★ 60.1K
9.2K
Earning Date
05-07-2026
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 23.78
N/A
EPS
★ N/A
N/A
Revenue
★ $368,288,000.00
$43,766,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$168.77
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
★ 589.88
52 Week Low
$2.69
$0.46
52 Week High
$5.99
$9.90

Technical Indicators

Market Signals
Indicator
UEIC
XLO
Relative Strength Index (RSI) 57.08 48.64
Support Level $4.12 $8.63
Resistance Level $5.67 $9.15
Average True Range (ATR) 0.24 0.24
MACD 0.04 0.00
Stochastic Oscillator 50.91 21.83

Price Performance

Historical Comparison
UEIC
XLO

About UEIC Universal Electronics Inc.

Universal Electronics Inc is engaged in universal wireless control solutions for the home. The company design, develop, manufacture, ship and support climate control solutions, wireless sensor and smart home control products, home entertainment control products, technology and software solutions and audio-video (AV) accessories that are used by the world's brands in the climate control, security, home automation, home appliance, home entertainment and consumer electronics markets.

About XLO Xilio Therapeutics Inc.

Xilio Therapeutics Inc is a clinical-stage biotechnology company focused on discovering and developing masked immuno-oncology (I-O) therapies to improve outcomes for people living with cancer. Leveraging its clinically validated masking technology and capabilities, the company develops I-O therapies designed to selectively activate within the tumor microenvironment to achieve durable efficacy without the severe side effects associated with systemically active I-O agents. Its integrated biology and protein engineering approach enables the design and development of potent masked biologics that are activated by tumor-specific proteases.

Share on Social Networks: